Combined UGT1A1 and UGT1A6 genotypes together with a stressful life event increase breast cancer risk

Breast Cancer Research and Treatment

Volumn 124, Issue 1, 2010, Pages 289-292

  Justenhoven, Christina ^a   Winter, Stefan ^a   Dünnebier, Thomas ^b   Hamann, Ute ^b   Baisch, Christian ^c   Rabstein, Sylvia ^d   Spickenheuer, Anne ^d   Harth, Volker ^d   Pesch, Beate ^d   Brüning, Thomas ^d   Ko, Yon Dschun ^c   Brauch, Hiltrud ^a  

^a UNIVERSITY OF TÜBINGEN   (Germany)

^b GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^c Johanniter Krankenhaus   (Germany)

^d INSTITUT DER RUHR UNIVERSITÄT BOCHUM IPA   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ATM PROTEIN; BRCA1 PROTEIN; BRCA2 PROTEIN; FIBROBLAST GROWTH FACTOR RECEPTOR 2; GLUCURONOSYLTRANSFERASE 1A1; GLUCURONOSYLTRANSFERASE 1A6; ONCOPROTEIN; PROTEIN BRIP1; PROTEIN CHEK; PROTEIN PALB2; UNCLASSIFIED DRUG;

BREAST CANCER; CANCER RISK; GENE FREQUENCY; GENE LOCUS; GENE MUTATION; GENETIC POLYMORPHISM; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE; HOMOZYGOSITY; HUMAN; LETTER; PRIORITY JOURNAL;

BREAST NEOPLASMS; CASE-CONTROL STUDIES; DNA MUTATIONAL ANALYSIS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GERMANY; GLUCURONOSYLTRANSFERASE; HUMANS; LIFE CHANGE EVENTS; LOGISTIC MODELS; ODDS RATIO; PHENOTYPE; POLYMORPHISM, SINGLE NUCLEOTIDE; PROMOTER REGIONS, GENETIC; RISK ASSESSMENT; RISK FACTORS; STRESS, PSYCHOLOGICAL;

EID: 77957714377     PISSN: 01676806     EISSN: 15737217     Source Type: Journal    
DOI: 10.1007/s10549-010-1093-7     Document Type: Letter

References (28)

1. DF Easton KA Pooley AM Dunning PD Pharoah D Thompson DG Ballinger JP Struewing J Morrison H Field R Luben N Wareham S Ahmed CS Healey R Bowman KB Meyer CA Haiman LK Kolonel BE Henderson ML Le P Brennan S Sangrajrang V Gaborieau F Odefrey CY Shen PE Wu HC Wang D Eccles DG Evans J Peto O Fletcher N Johnson S Seal MR Stratton N Rahman G Chenevix-Trench SE Bojesen BG Nordestgaard CK Axelsson M Garcia-Closas L Brinton S Chanock J Lissowska B Peplonska H Nevanlinna R Fagerholm H Eerola D Kang KY Yoo DY Noh SH Ahn DJ Hunter SE Hankinson DG Cox P Hall S Wedren J Liu YL Low N Bogdanova P Schurmann T Dork RA Tollenaar CE Jacobi P Devilee JG Klijn AJ Sigurdson MM Doody BH Alexander J Zhang A Cox IW Brock G MacPherson MW Reed FJ Couch EL Goode JE Olson H Meijers-Heijboer OA van den A Uitterlinden F Rivadeneira RL Milne G Ribas A Gonzalez-Neira J Benitez JL Hopper M McCredie M Southey GG Giles C Schroen C Justenhoven H Brauch U Hamann YD Ko AB Spurdle J Beesley X Chen A Mannermaa VM Kosma V Kataja J Hartikainen NE Day DR Cox BA Ponder 2007 Genome-wide association study identifies novel breast cancer susceptibility loci Nature 447 1087 1093 1:CAS:528:DC%2BD2sXmvFKmurc%3D 10.1038/nature05887 17529967
2. D Ford DF Easton M Stratton S Narod D Goldgar P Devilee DT Bishop B Weber G Lenoir J Chang-Claude H Sobol MD Teare J Struewing A Arason S Scherneck J Peto TR Rebbeck P Tonin S Neuhausen R Barkardottir J Eyfjord H Lynch BA Ponder SA Gayther M Zelada-Hedman, et al. 1998 Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The Breast Cancer Linkage Consortium Am J Hum Genet 62 676 689 1:CAS:528:DyaK1MXlvFeh 10.1086/301749 9497246
3. S Narod D Ford P Devilee RB Barkardottir J Eyfjord G Lenoir O Serova D Easton D Goldgar 1995 Genetic heterogeneity of breast-ovarian cancer revisited. Breast Cancer Linkage Consortium Am J Hum Genet 57 957 958 1:STN:280: DyaK28%2FivFaqsg%3D%3D 7573057
4. BS Hulka PG Moorman 2001 Breast cancer: hormones and other risk factors Maturitas 38 103 113 1:CAS:528:DC%2BD3MXislensro%3D 10.1016/S0378-5122(00)00196- 1 11311599
5. JL Kelsey MD Gammon 1991 The epidemiology of breast cancer CA Cancer J Clin 41 146 165 1:STN:280:DyaK3M3gvVGrsg%3D%3D 10.3322/canjclin.41.3.146 1902137
6. J Kruk HY boul-Enein 2004 Psychological stress and the risk of breast cancer: a case-control study Cancer Detect Prev 28 399 408 10.1016/j.cdp.2004. 07.009 15582263
7. K Lillberg PK Verkasalo J Kaprio L Teppo H Helenius M Koskenvuo 2003 Stressful life events and risk of breast cancer in 10,808 women: a cohort study Am J Epidemiol 157 415 423 10.1093/aje/kwg002 12615606
8. A Steptoe J Wardle 1994 What the experts think: a European survey of expert opinion about the influence of lifestyle on health Eur J Epidemiol 10 195 203 1:STN:280:DyaK2M7htlSqsw%3D%3D 10.1007/BF01730370 7813698
9. P Chorot B Sandin 1994 Life events and stress reactivity as predictors of cancer, coronary heart disease and anxiety disorders Int J Psychosom 41 34 40 1:STN:280:DyaK2M7ks1agsg%3D%3D 7843864
10. A Ginsberg S Price D Ingram E Nottage 1996 Life events and the risk of breast cancer: a case-control study Eur J Cancer 32A 2049 2052 1:STN:280:DyaK2s7mslSmtg%3D%3D 10.1016/S0959-8049(96)00275-4 9014743
11. RH Rahe L Bennett M Romo P Siltanen RJ Arthur 1973 Subjects' recent life changes and coronary heart disease in Finland Am J Psychiatry 130 1222 1226 1:STN:280:DyaE2c%2Fht1Ohsw%3D%3D 4746028
12. S Cohen BS Rabin 1998 Psychologic stress, immunity, and cancer J Natl Cancer Inst 90 3 4 1:STN:280:DyaK1c%2FovFSnug%3D%3D 10.1093/jnci/90.1.3 9428772
13. B Garssen K Goodkin 1999 On the role of immunological factors as mediators between psychosocial factors and cancer progression Psychiatry Res 85 51 61 1:STN:280:DyaK1M3gvFKqsw%3D%3D 10.1016/S0165-1781(99)00008-6 10195316
14. R McGee S Williams M Elwood 1996 Are life events related to the onset of breast cancer Psychol Med 26 441 447 1:STN:280:DyaK28zhtVGnsQ%3D%3D 10.1017/S0033291700035522 8733203
15. DP Funch JR Marshall 1984 Measuring life stress: factors affecting fall-off in the reporting of life events J Health Soc Behav 25 453 464 1:STN:280:DyaL2M7gs1WhtA%3D%3D 10.2307/2136382 6520364
16. I Levav R Kohn J Iscovich JH Abramson WY Tsai D Vigdorovich 2000 Cancer incidence and survival following bereavement Am J Public Health 90 1601 1607 1:STN:280:DC%2BD3cvnvFWmtw%3D%3D 10.2105/AJPH.90.10.1601 11029995
17. PI Mackenzie IS Owens B Burchell KW Bock A Bairoch A Belanger S Fournel-Gigleux M Green DW Hum T Iyanagi D Lancet P Louisot J Magdalou JR Chowdhury JK Ritter H Schachter TR Tephly KF Tipton DW Nebert 1997 The UDP glycosyltransferase gene superfamily: recommended nomenclature update based on evolutionary divergence Pharmacogenetics 7 255 269 1:CAS:528:DyaK2sXmt1WqtLo%3D 10.1097/00008571-199708000-00001 9295054
18. S Riedmaier K Klein U Hofmann JE Keskitalo PJ Neuvonen M Schwab M Niemi UM Zanger 2010 UDP-glucuronosyltransferase (UGT) polymorphisms affect atorvastatin lactonization in vitro and in vivo Clin Pharmacol Ther 87 65 73 1:CAS:528:DC%2BD1MXhsFOms7bN 10.1038/clpt.2009.181 19794410
19. JO Miners PI Mackenzie 1991 Drug glucuronidation in humans Pharmacol Ther 51 347 369 1:CAS:528:DyaK38Xht1ShsL8%3D 10.1016/0163-7258(91)90065-T 1792239
20. JO Miners RA McKinnon PI Mackenzie 2002 Genetic polymorphisms of UDP-glucuronosyltransferases and their functional significance Toxicology 181-182 453 456 10.1016/S0300-483X(02)00449-3 12505351
21. E Beutler T Gelbart A Demina 1998 Racial variability in the UDP-glucuronosyltransferase 1 (UGT1A1) promoter: a balanced polymorphism for regulation of bilirubin metabolism? Proc Natl Acad Sci USA 95 8170 8174 1:CAS:528:DyaK1cXks1Skur4%3D 10.1073/pnas.95.14.8170 9653159
22. M Ciotti A Marrone C Potter IS Owens 1997 Genetic polymorphism in the human UGT1A6 (planar phenol) UDP-glucuronosyltransferase: pharmacological implications Pharmacogenetics 7 485 495 1:CAS:528:DyaK2sXotVChtrw%3D 10.1097/00008571-199712000-00007 9429234
23. C Kohle B Mohrle PA Munzel M Schwab D Wernet OA Badary KW Bock 2003 Frequent co-occurrence of the TATA box mutation associated with Gilbert's syndrome (UGT1A1*28) with other polymorphisms of the UDP- glucuronosyltransferase-1 locus (UGT1A6*2 and UGT1A7*3) in Caucasians and Egyptians Biochem Pharmacol 65 1521 1527 1:CAS:528: DC%2BD3sXjsVeqtr4%3D 10.1016/S0006-2952(03)00074-1 12732365
24. TheMARIE-GENICA Consortium on Genetic Susceptibility for Menopausal Hormone Therapy Related Breast Cancer Risk 2010 Genetic polymorphisms in phase I and phase II enzymes and breast cancer risk associated with menopausal hormone therapy in postmenopausal women Breast Cancer Res Treat 119 463 474 10.1007/s10549-009-0407-0
25. A Vogel S Kneip A Barut U Ehmer RH Tukey MP Manns CP Strassburg 2001 Genetic link of hepatocellular carcinoma with polymorphisms of the UDP-glucuronosyltransferase UGT1A7 gene Gastroenterology 121 1136 1144 1:CAS:528:DC%2BD3MXpt1Srsb8%3D 10.1053/gast.2001.28655 11677206
26. C Justenhoven CB Pierl S Haas HP Fischer C Baisch U Hamann V Harth B Pesch T Bruning C Vollmert T Illig J Dippon YD Ko H Brauch 2008 The CYP1B1-1358-GG genotype is associated with estrogen receptor-negative breast cancer Breast Cancer Res Treat 111 171 177 1:CAS:528:DC%2BD1cXos1Wntrc%3D 10.1007/s10549-007-9762-x 17922187
27. B Pesch Y Ko H Brauch U Hamann V Harth S Rabstein C Pierl HP Fischer C Baisch C Justenhoven U Ranft T Bruning 2005 Factors modifying the association between hormone-replacement therapy and breast cancer risk Eur J Epidemiol 20 699 711 10.1007/s10654-005-0032-0 16151884
28. T Key P Appleby I Barnes G Reeves 2002 Endogenous sex hormones and breast cancer in postmenopausal women: reanalysis of nine prospective studies J Natl Cancer Inst 94 606 616 1:CAS:528:DC%2BD38Xjs1eit7w%3D 11959894